66 related articles for article (PubMed ID: 25856400)
1. Correction: Enhanced cellular uptake of albumin-based lyophilisomes when functionalized with cell-penetrating peptide TAT in HeLa cells.
PLOS ONE Staff
PLoS One; 2015; 10(4):e0124465. PubMed ID: 25856400
[No Abstract] [Full Text] [Related]
2. Enhanced cellular uptake of albumin-based lyophilisomes when functionalized with cell-penetrating peptide TAT in HeLa cells.
van Bracht E; Versteegden LR; Stolle S; Verdurmen WP; Woestenenk R; Raavé R; Hafmans T; Oosterwijk E; Brock R; van Kuppevelt TH; Daamen WF
PLoS One; 2014; 9(11):e110813. PubMed ID: 25369131
[TBL] [Abstract][Full Text] [Related]
3. Specific targeting of tumor cells by lyophilisomes functionalized with antibodies.
van Bracht E; Stolle S; Hafmans TG; Boerman OC; Oosterwijk E; van Kuppevelt TH; Daamen WF
Eur J Pharm Biopharm; 2014 May; 87(1):80-9. PubMed ID: 24463217
[TBL] [Abstract][Full Text] [Related]
4. Synthesis, cellular uptake and HIV-1 Tat-dependent trans-activation inhibition activity of oligonucleotide analogues disulphide-conjugated to cell-penetrating peptides.
Turner JJ; Arzumanov AA; Gait MJ
Nucleic Acids Res; 2005; 33(1):27-42. PubMed ID: 15640444
[TBL] [Abstract][Full Text] [Related]
5. Lyophilisomes as a new generation of drug delivery capsules.
van Bracht E; Raavé R; Verdurmen WP; Wismans RG; Geutjes PJ; Brock RE; Oosterwijk E; van Kuppevelt TH; Daamen WF
Int J Pharm; 2012 Dec; 439(1-2):127-35. PubMed ID: 23069914
[TBL] [Abstract][Full Text] [Related]
6. Characterisation of cell-penetrating peptide-mediated peptide delivery.
Jones SW; Christison R; Bundell K; Voyce CJ; Brockbank SM; Newham P; Lindsay MA
Br J Pharmacol; 2005 Aug; 145(8):1093-102. PubMed ID: 15937518
[TBL] [Abstract][Full Text] [Related]
7. Convergent synthesis and cellular uptake of multivalent cell penetrating peptides derived from Tat, Antp, pVEC, TP10 and SAP.
Eggimann GA; Buschor S; Darbre T; Reymond JL
Org Biomol Chem; 2013 Oct; 11(39):6717-33. PubMed ID: 23933745
[TBL] [Abstract][Full Text] [Related]
8. Tat(48-60) peptide amino acid sequence is not unique in its cell penetrating properties and cell-surface glycosaminoglycans inhibit its cellular uptake.
Subrizi A; Tuominen E; Bunker A; Róg T; Antopolsky M; Urtti A
J Control Release; 2012 Mar; 158(2):277-85. PubMed ID: 22100438
[TBL] [Abstract][Full Text] [Related]
9. Enhanced cellular uptake of a TAT-conjugated peptide inhibitor targeting the polo-box domain of polo-like kinase 1.
Kim SM; Chae MK; Lee C; Yim MS; Bang JK; Ryu EK
Amino Acids; 2014 Nov; 46(11):2595-603. PubMed ID: 25151148
[TBL] [Abstract][Full Text] [Related]
10. Synergistic effects of cell-penetrating peptide Tat and fusogenic peptide HA2-enhanced cellular internalization and gene transduction of organosilica nanoparticles.
Ye SF; Tian MM; Wang TX; Ren L; Wang D; Shen LH; Shang T
Nanomedicine; 2012 Aug; 8(6):833-41. PubMed ID: 22033082
[TBL] [Abstract][Full Text] [Related]
11. Study of uptake of cell penetrating peptides and their cargoes in permeabilized wheat immature embryos.
Chugh A; Eudes F
FEBS J; 2008 May; 275(10):2403-14. PubMed ID: 18397318
[TBL] [Abstract][Full Text] [Related]
12. Cell-penetrating peptide conjugates of peptide nucleic acids (PNA) as inhibitors of HIV-1 Tat-dependent trans-activation in cells.
Turner JJ; Ivanova GD; Verbeure B; Williams D; Arzumanov AA; Abes S; Lebleu B; Gait MJ
Nucleic Acids Res; 2005; 33(21):6837-49. PubMed ID: 16321967
[TBL] [Abstract][Full Text] [Related]
13. Internalization routes of cell-penetrating melanoma antigen peptides into human dendritic cells.
Buhl T; Braun A; Forkel S; Möbius W; van Werven L; Jahn O; Rezaei-Ghaleh N; Zweckstetter M; Mempel M; Schön MP; Haenssle HA
Exp Dermatol; 2014 Jan; 23(1):20-6. PubMed ID: 24372650
[TBL] [Abstract][Full Text] [Related]
14. Cellular uptake [correction of utake] of the Tat peptide: an endocytosis mechanism following ionic interactions.
Vives E
J Mol Recognit; 2003; 16(5):265-71. PubMed ID: 14523939
[TBL] [Abstract][Full Text] [Related]
15. Induction of splice correction by cell-penetrating peptide nucleic acids.
El-Andaloussi S; Johansson HJ; Lundberg P; Langel U
J Gene Med; 2006 Oct; 8(10):1262-73. PubMed ID: 16900561
[TBL] [Abstract][Full Text] [Related]
16. Enhanced nuclear import and transfection efficiency of TAT peptide-based gene delivery systems modified by additional nuclear localization signals.
Yi WJ; Yang J; Li C; Wang HY; Liu CW; Tao L; Cheng SX; Zhuo RX; Zhang XZ
Bioconjug Chem; 2012 Jan; 23(1):125-34. PubMed ID: 22148643
[TBL] [Abstract][Full Text] [Related]
17. Enhanced cellular uptake with a cobaltacarborane-porphyrin-HIV-1 Tat 48-60 conjugate.
Sibrian-Vazquez M; Hao E; Jensen TJ; Vicente MG
Bioconjug Chem; 2006; 17(4):928-34. PubMed ID: 16848399
[TBL] [Abstract][Full Text] [Related]
18. A comprehensive model for the cellular uptake of cationic cell-penetrating peptides.
Duchardt F; Fotin-Mleczek M; Schwarz H; Fischer R; Brock R
Traffic; 2007 Jul; 8(7):848-66. PubMed ID: 17587406
[TBL] [Abstract][Full Text] [Related]
19. Synergistic targeted delivery of payload into tumor cells by dual-ligand liposomes co-modified with cholesterol anchored transferrin and TAT.
Tang J; Zhang L; Liu Y; Zhang Q; Qin Y; Yin Y; Yuan W; Yang Y; Xie Y; Zhang Z; He Q
Int J Pharm; 2013 Sep; 454(1):31-40. PubMed ID: 23850793
[TBL] [Abstract][Full Text] [Related]
20. Enhanced tumor accumulation and cellular uptake of liposomes modified with ether-bond linked cholesterol derivatives.
Ran R; Zhang L; Tang J; Yin YJ; Qin Y; Liu YY; Zhang ZR; He Q
Pharmazie; 2013 Aug; 68(8):668-74. PubMed ID: 24020121
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
